A citation-based method for searching scientific literature

Laura Escudero, Francisco Martínez-Ricarte, Joan Seoane. Cancers (Basel) 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Integrated molecular analysis of clear-cell renal cell carcinoma.
Yusuke Sato, Tetsuichi Yoshizato, Yuichi Shiraishi, Shigekatsu Maekawa, Yusuke Okuno, Takumi Kamura, Teppei Shimamura, Aiko Sato-Otsubo, Genta Nagae, Hiromichi Suzuki,[...]. Nat Genet 2013
639
50

Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo.
Rituparna Das, Rakesh Verma, Mario Sznol, Chandra Sekhar Boddupalli, Scott N Gettinger, Harriet Kluger, Margaret Callahan, Jedd D Wolchok, Ruth Halaban, Madhav V Dhodapkar,[...]. J Immunol 2015
251
50

Acetate Promotes T Cell Effector Function during Glucose Restriction.
Jing Qiu, Matteo Villa, David E Sanin, Michael D Buck, David O'Sullivan, Reagan Ching, Mai Matsushita, Katarzyna M Grzes, Frances Winkler, Chih-Hao Chang,[...]. Cell Rep 2019
95
50

Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors - A systematic review and meta-analysis.
Syed Hussaini, Rania Chehade, Ronald Gabriel Boldt, Jacques Raphael, Phillip Blanchette, Saman Maleki Vareki, Ricardo Fernandes. Cancer Treat Rev 2021
22
50

Radiation and Immune Checkpoint Blockade: From Bench to Clinic.
Jacob E Shabason, Andy J Minn. Semin Radiat Oncol 2017
28
50

Cytokines in radiobiological responses: a review.
Dörthe Schaue, Evelyn L Kachikwu, William H McBride. Radiat Res 2012
210
50

Combining DNA damaging therapeutics with immunotherapy: more haste, less speed.
Jessica S Brown, Raghav Sundar, Juanita Lopez. Br J Cancer 2018
115
50

T cell metabolic fitness in antitumor immunity.
Peter J Siska, Jeffrey C Rathmell. Trends Immunol 2015
151
50

2020 ASHG awards and addresses.
. Am J Hum Genet 2021
1
100

Association between immune-related adverse events and prognosis in patients with metastatic renal cell carcinoma treated with nivolumab.
Hiroki Ishihara, Toshio Takagi, Tsunenori Kondo, Chie Homma, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Junpei Iizuka, Hirohito Kobayashi, Masayoshi Okumi,[...]. Urol Oncol 2019
29
50

Defining 'T cell exhaustion'.
Christian U Blank, W Nicholas Haining, Werner Held, Patrick G Hogan, Axel Kallies, Enrico Lugli, Rachel C Lynn, Mary Philip, Anjana Rao, Nicholas P Restifo,[...]. Nat Rev Immunol 2019
268
50

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
Börje Ljungberg, Laurance Albiges, Yasmin Abu-Ghanem, Karim Bensalah, Saeed Dabestani, Sergio Fernández-Pello, Rachel H Giles, Fabian Hofmann, Milan Hora, Markus A Kuczyk,[...]. Eur Urol 2019
465
50

The immunology of renal cell carcinoma.
C Marcela Díaz-Montero, Brian I Rini, James H Finke. Nat Rev Nephrol 2020
27
50

IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival.
Derek A Wainwright, Irina V Balyasnikova, Alan L Chang, Atique U Ahmed, Kyung-Sub Moon, Brenda Auffinger, Alex L Tobias, Yu Han, Maciej S Lesniak. Clin Cancer Res 2012
235
50

Renal cell carcinoma.
James J Hsieh, Mark P Purdue, Sabina Signoretti, Charles Swanton, Laurence Albiges, Manuela Schmidinger, Daniel Y Heng, James Larkin, Vincenzo Ficarra. Nat Rev Dis Primers 2017
769
50

4-1BB signaling beyond T cells.
Dass S Vinay, Byoung S Kwon. Cell Mol Immunol 2011
79
50

A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer.
Hagma H Workel, Joyce M Lubbers, Roland Arnold, Thalina M Prins, Pieter van der Vlies, Kim de Lange, Tjalling Bosse, Inge C van Gool, Florine A Eggink, Maartje C A Wouters,[...]. Cancer Immunol Res 2019
39
50

Ionizing radiation modulates human macrophages towards a pro-inflammatory phenotype preserving their pro-invasive and pro-angiogenic capacities.
Ana Teresa Pinto, Marta Laranjeiro Pinto, Ana Patrícia Cardoso, Cátia Monteiro, Marta Teixeira Pinto, André Filipe Maia, Patrícia Castro, Rita Figueira, Armanda Monteiro, Margarida Marques,[...]. Sci Rep 2016
89
50

The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
Maxine Sun, Guillermo De Velasco, Priscilla K Brastianos, Ayal A Aizer, Allison Martin, Raphael Moreira, Paul L Nguyen, Quoc-Dien Trinh, Toni K Choueiri. Eur Urol Focus 2019
24
50

Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma.
Stephanie G C Kroeze, Corinna Fritz, Jana Schaule, Shankar Siva, Klaus H Kahl, Nora Sundahl, Oliver Blanck, David Kaul, Sonja Adebahr, Joost J C Verhoeff,[...]. BJU Int 2021
7
50

The Interdisciplinary Management of Brain Metastases.
Kirsten Schmieder, Ulrich Keilholz, Stephanie Combs. Dtsch Arztebl Int 2016
9
50

The promise and challenges of immune agonist antibody development in cancer.
Patrick A Mayes, Kenneth W Hance, Axel Hoos. Nat Rev Drug Discov 2018
126
50

Radiation and immunotherapy: a synergistic combination.
Anusha Kalbasi, Carl H June, Naomi Haas, Neha Vapiwala. J Clin Invest 2013
167
50

Tumor-infiltrating TNFRSF9+ CD8+ T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response.
Yaohui Li, Zewei Wang, Wenbin Jiang, Han Zeng, Zhaopei Liu, Zhiyuan Lin, Yang Qu, Ying Xiong, Jiajun Wang, Yuan Chang,[...]. Oncoimmunology 2020
5
50


Targeted therapies for renal cell carcinoma.
Edwin M Posadas, Suwicha Limvorasak, Robert A Figlin. Nat Rev Nephrol 2017
104
50

Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment.
Erik S Anderson, Michael A Postow, Jedd D Wolchok, Robert J Young, Åse Ballangrud, Timothy A Chan, Yoshiya Yamada, Kathryn Beal. J Immunother Cancer 2017
64
50

In-vitro GIT Tolerance of Microencapsulated Bifidobacterium bifidum ATCC 35914 Using Polysaccharide-Protein Matrix.
Rabia Iqbal, Tahir Zahoor, Nuzhat Huma, Amer Jamil, Gülhan Ünlü. Probiotics Antimicrob Proteins 2019
9
50

Targeting CDK4/6 in patients with cancer.
Erika Hamilton, Jeffrey R Infante. Cancer Treat Rev 2016
190
50

RCC Immune Microenvironment Subsequent to Targeted Therapy: A Friend or a Foe?
Wenjin Chen, Xiuwu Pan, Xingang Cui. Front Oncol 2020
2
50

Awakening the immune system with radiation: Optimal dose and fractionation.
Saumil J Gandhi, Andy J Minn, Robert H Vonderheide, E John Wherry, Stephen M Hahn, Amit Maity. Cancer Lett 2015
65
50

Tumor microenvironment: Sanctuary of the devil.
Lanlan Hui, Ye Chen. Cancer Lett 2015
316
50

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Christopher J Ricketts, Aguirre A De Cubas, Huihui Fan, Christof C Smith, Martin Lang, Ed Reznik, Reanne Bowlby, Ewan A Gibb, Rehan Akbani, Rameen Beroukhim,[...]. Cell Rep 2018
241
50

Emerging and investigational targeted chemotherapy and immunotherapy agents for metastatic brain tumors.
J Tanner McMahon, Razan R Faraj, David Cory Adamson. Expert Opin Investig Drugs 2020
3
50

Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practice.
Richard W Joseph, Gurkamal Chatta, Ulka Vaishampayan. Urol Oncol 2017
12
50

T Cell Dysfunction in Cancer.
Daniela S Thommen, Ton N Schumacher. Cancer Cell 2018
348
50

Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients.
Yu Qi, Yu Xia, Zhiyuan Lin, Yang Qu, Yangyang Qi, Yifan Chen, Quan Zhou, Han Zeng, Jiajun Wang, Yuan Chang,[...]. Cancer Immunol Immunother 2020
25
50

Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.
Ronan Flippot, Cécile Dalban, Brigitte Laguerre, Delphine Borchiellini, Gwénaelle Gravis, Sylvie Négrier, Christine Chevreau, Florence Joly, Lionnel Geoffrois, Sylvain Ladoire,[...]. J Clin Oncol 2019
59
50

Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 Treatment.
Maike Trommer-Nestler, Simone Marnitz, Martin Kocher, Daniel Rueß, Max Schlaak, Sebastian Theurich, Michael von Bergwelt-Baildon, Janis Morgenthaler, Karolina Jablonska, Eren Celik,[...]. Int J Mol Sci 2018
21
50

Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters.
Shuiying Hu, Zhaoyuan Chen, Ryan Franke, Shelley Orwick, Ming Zhao, Michelle A Rudek, Alex Sparreboom, Sharyn D Baker. Clin Cancer Res 2009
116
50

Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways.
Sarah R Jacobs, Catherine E Herman, Nancie J Maciver, Jessica A Wofford, Heather L Wieman, Jeremy J Hammen, Jeffrey C Rathmell. J Immunol 2008
467
50

Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial.
Robert J Motzer, Brian I Rini, David F McDermott, Bruce G Redman, Timothy M Kuzel, Michael R Harrison, Ulka N Vaishampayan, Harry A Drabkin, Saby George, Theodore F Logan,[...]. J Clin Oncol 2015
682
50

Checkpoint inhibitor immunotherapy in kidney cancer.
Wenxin Xu, Michael B Atkins, David F McDermott. Nat Rev Urol 2020
55
50

Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study.
David F McDermott, Jeffrey A Sosman, Mario Sznol, Christophe Massard, Michael S Gordon, Omid Hamid, John D Powderly, Jeffrey R Infante, Marcella Fassò, Yan V Wang,[...]. J Clin Oncol 2016
357
50


Brain Metastasis From Renal-Cell Carcinoma: An Institutional Study.
Alfredo Suarez-Sarmiento, Kevin A Nguyen, Jamil S Syed, Adam Nolte, Kamyar Ghabili, Michelle Cheng, Sandy Liu, Veronica Chiang, Harriet Kluger, Michael Hurwitz,[...]. Clin Genitourin Cancer 2019
20
50

Prognosis of Incidental Brain Metastases in Patients With Advanced Renal Cell Carcinoma.
Ritesh R Kotecha, Ronan Flippot, Taylor Nortman, Annalisa Guida, Sujata Patil, Bernard Escudier, Robert J Motzer, Laurence Albiges, Martin H Voss. J Natl Compr Canc Netw 2021
4
50

Regulatory T cells actively infiltrate metastatic brain tumors.
Adam Quasar Sugihara, Cleo E Rolle, Maciej S Lesniak. Int J Oncol 2009
31
50

A review of human cell radiosensitivity in vitro.
P J Deschavanne, B Fertil. Int J Radiat Oncol Biol Phys 1996
175
50

A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade.
Daniela S Thommen, Viktor H Koelzer, Petra Herzig, Andreas Roller, Marcel Trefny, Sarah Dimeloe, Anna Kiialainen, Jonathan Hanhart, Catherine Schill, Christoph Hess,[...]. Nat Med 2018
366
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.